Dietary prevention of coronary artery disease

References

• NIH Consensus Development Conference Summary. Lowering blood cholesterol to prevent heart disease. JAMA 1985: 253(14): 2080–6
   PubMed Web of Science ®Google Scholar
• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986: 256(20): 2835–8
   PubMed Web of Science ®Google Scholar
• Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356. 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986: 256(20): 2823–8
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Gau GT, Squires RW, et al. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988: 63(6): 605–21
   PubMed Web of Science ®Google Scholar
• Gutowski T, Adelson R, Cohen MV. Poor acceptance of blood lipids as treatable risk factor among cardiologists. (Abstr) Circulation 1988: 78(4): II–384
   Google Scholar
• Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985: 312(13): 805–11
   PubMed Web of Science ®Google Scholar
• Kushi LH, Lew RA, Stare FJ. et al. Diet and 20-year mortality from coronary heart disease: the Ireland- Boston Diet-Heart Study. N Engl J Med 1985: 312(13): 811–8
   PubMed Web of Science ®Google Scholar
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984: 251 (3): 351–64
   PubMed Web of Science ®Google Scholar
• Canner PL, Beige KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986: 8(6): 1245–55
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987: 257(23): 3233–40
   PubMed Web of Science ®Google Scholar
• Flick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317(20): 1237–45
   PubMed Web of Science ®Google Scholar
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988: 148(1): 36–69
   PubMed Web of Science ®Google Scholar
• Castelli WP, Griffin GC. How to help patients cut down on saturated fat: a simple strategy. Postgrad Med 1988: 84(3): 44–56
   PubMed Web of Science ®Google Scholar
• Spady DK. Dietactry JM. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc Natl Acad Sci USA 1985: 82(13): 4526–30
   Google Scholar
• Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986: 232(4746): 34–47
   PubMed Web of Science ®Google Scholar
• Grundy SM. Dietary therapy for different forms of hyperlipoproteinemia. Circulation 1987: 76(3): 523–8
   PubMed Web of Science ®Google Scholar
• Hegsted DM, McGandy RB, Myers ML, et al. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965: 17: 281–95
   PubMed Web of Science ®Google Scholar
• Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. Metabolism 1965: 14(Jul): 747–87
   PubMed Web of Science ®Google Scholar
• Schonfeld G. Patsch W. Rudel LL. et al. Effecte of dietary cholesterol and fatty acidson plasma lipoproteins. J Clin Invest 1982: 69(5): 1072–80
   PubMed Web of Science ®Google Scholar
• Vega GL, Groszek E, Wolf R, et al. Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins. J Lipid Res 1982: 23(6): 811–22
   PubMed Web of Science ®Google Scholar
• Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. n. The effect of cholesterol in the diet. Metabolism 1965: 14(Jul): 759–65
   PubMed Web of Science ®Google Scholar
• Grundy SM. Comparison of monounsaturated fatty adds and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986: 314(12): 745–8
   PubMed Web of Science ®Google Scholar
• Zilversmit DB. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 1973: 33(6): 633–8
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986: 90(2): 275–9
   PubMed Web of Science ®Google Scholar
• La vie CJ, Ventura HO, Messerli FH. Cardiopathy of obesity. IM—Intern Med Specialist 1988: 9(10): 57–71
   Google Scholar
• Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during Weight loss through dieting as compared with exercise. N Engl J Med 1988: 319(18): 1173–9
   PubMed Web of Science ®Google Scholar
• Dietary guidelines for healthy American adults: a statement for physicians and health professionals by the Nutrition Committee, American Heart Association. Circulation 1986: 74(6): 1465–8A
   Web of Science ®Google Scholar
• Griffin GC, Castelli WP. Good fat, bad fat: how to lower your cholesterol& beat the odds of a heart attack. Tucson: Fisher Books. 1989
   Google Scholar
• Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Eng) J Med 1988: 318(19): 1244–8
   PubMed Web of Science ®Google Scholar
• Keys A. Coronary heart disease in seven countries. Circulation 1970: 41(4 Suppl 1): 1–211
   Web of Science ®Google Scholar
• Rosenthal MB, Barnard RJ, Rose DP, et al. Effects of a high-complex-carbohydrate, low-fat, low- cholesterol diet on levels of serum lipids and estradiol. Am J Med 1985: 78(1): 23–7
   PubMed Web of Science ®Google Scholar
• Sturdevant RA, Pearce ML, Dayton S. Increased prevalence of cholelithiasis in men ingesting a serum- cholesterol-lowering diet N Engl J Med 1973: 288(1): 24–7
   PubMed Web of Science ®Google Scholar
• Bansal BR, Rhoads JE Jr, Bansal SC. Effects of diet on colon carcinogenesis and the immune system in rats treated with 1.2-dimethylhydraztne. Cancer Res 1978: 38(10): 3293–303
   PubMed Web of Science ®Google Scholar
• Carroll KK, Gammal EB, Plunkett ER. Dietary fat and mammary cancer. Can Med Assoc J 1968: 98(12): 590–4
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Squires W, Gau GT. What is the role of fish and fish oils in the primary and secondary prevention of cardiovascular disease? J Cardiopul Rehabll 1987: 7: 526–33
   Google Scholar
• Sinclair HM. The diet of Canadian Indians and Eskimos. Proc NutrSoc 1953: 12: 69–82
   Web of Science ®Google Scholar
• Bang HO, Dyerberg J. Lipid metabolism and Ischemic heart disease in Greenland Eskimos. Adv Lipid Res 1980: 3: 1–22
   Google Scholar
• Kagawa T, Nishizawa M, Suzuki M, et al. Elcosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol (Tokyo) 1982: 28(4): 441–53
   Google Scholar
• Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985: 312(19): 1205–9
   PubMed Web of Science ®Google Scholar
• Shekelle RB, Missell LV, Paul O. et al. Fish consumption and mortality from coronary heart disease. (Letter) N Engl J Med 1985: 313(13): 820
   PubMedGoogle Scholar
• Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. (Letter) N Engl J Med 1985: 313(13): 820–1
   PubMedGoogle Scholar
• Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. (Letter) N Engl J Med 1985: 313(13): 821–2
   Web of Science ®Google Scholar
• Lavie CJ, Squires RW, Gau GT. Preventive cardiology: what is the value of antiplatelet agents and fish oils? South Med J 1988: 81(9): 1145–50
   PubMed Web of Science ®Google Scholar
• Dehmer GJ, Popma JJ, van den Berg EK, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988: 319(12): 733–40
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Squires RW, Gau GT. Prevention of cardiovascular disease: of what value are risk factor modification, exercise, fish consumption, and aspirin therapy? Postgrad Med 1987: 81(5): 52–72
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Gau GT. Marine omega-3 fatty adds and atherosclerosis (Letter) Ann Intern Med 1988: 108(3): 483–5
   PubMed Web of Science ®Google Scholar
• Harris WS, Dujovne CA, Zucker M, et al. Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients: a placebo-controlled trial. Ann intern Med 1988: 109(6): 465–70
   PubMed Web of Science ®Google Scholar
• Anderson JW, Tietyen-Clark J. Dietary fiber: hyperlipidemla, hypertension, and coronary heart disease. Am J Gastroenterol 1986: 81(10): 907–19
   PubMed Web of Science ®Google Scholar
• Anderson JW. Dietary fiber, lipids and atherosclerosis. Am J Cardiol 1987: 60(12): 17–22G
   Web of Science ®Google Scholar
• Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J 1977: 2(6098): 1307–14
   PubMed Web of Science ®Google Scholar
• Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes: the Zutphen study. Lancet 1982: 2(8297): 518–22
   PubMed Web of Science ®Google Scholar
• Liu K, Stamler J, MOM D, et al. Dietary cholesterol, fat, and fibre, and colon-cancer mortality: an analysis of International data. Lancet 1979: 2(8146): 782–5
   PubMed Web of Science ®Google Scholar
• Kushi LH, Lew RA, Stare FJ, et al. Diet and 20-year mortality from coronary heart disease: the Ireland-Boston Diet-Heart Study. N Engl J Med 1985: 312(13): 811–8
   PubMed Web of Science ®Google Scholar
• Anderson JW, Story L, Sieling B, et al. Hypocho- lesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 1984: 40(6): 1146–55
   PubMed Web of Science ®Google Scholar
• Anderson JW, Chen W-JL. Legumes and their soluble fiber effect on cholesterol-rich lipoproteins. In: Furda I, ed. Unconventional sources of dietary fiber: physiological and in vitro functional properties. Washington, DC: Am Chemical Society, 1983: 51–9
   Google Scholar
• Kirby RW, Anderson JW, Sieling B, et al. Oatbran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981: 34(5): 824–9
   PubMed Web of Science ®Google Scholar
• Cerda JJ, Robbing FL, Burgin CW, et al. The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clin Cardiol 1988: 11: 589–94
   PubMed Web of Science ®Google Scholar
• Superko HR, Haskell WL, Sawrey-Kubicek L, et al. Effects of solid and liquid guar gum on plasma cholesterol and triglyceride concentrations in moderate hypercholesterolemia. Am J Cardiol 1988: 62(1): 51–5
   PubMed Web of Science ®Google Scholar
• Anderson JW, Zettwoch N, Feldman T, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988: 148(2): 292–6
   PubMedGoogle Scholar
• Kinosian BP, Eisenberg JM. Cutting into cholesterol: cost-effective alternatives for treating hypercholesterolemia. JAMA 1988: 259(15): 2249–54
   PubMed Web of Science ®Google Scholar
• Eichner ER. The caffeine controversy: effects on endurance and cholesterol. Phys Sportsmed 1986: 14(12): 124–32
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Mead LA, Liang KT. et al. Coffee consumption and the incidence of coronary heart disease. N Engl J Med 1986: 315(16): 977–82
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Palmer JR, Kelly JP et al. Coffee drinking and nonfatal myocardial infarction in men under 55 years of age. Am J Epidemiol 1988: 128(3): 570–8
   PubMed Web of Science ®Google Scholar
• Forde OH, Knutsen SF, Arnesen E, et al. The Tromsø heart study: coffee consumption and serum lipid concentrations in men with hypercholesterolaemia: a randomised intervention study. Br Med J (Clin Res) 1985: 290(6472): 893–5
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Petitti DB, Armstrong MA, et al. Coffee, tea and cholesterol. Am J Cardiol 1985: 55(5): 577–8
   PubMed Web of Science ®Google Scholar
• Marmot MG, Rose G, Shipley MJ, et al. Alcohol and mortality: a U-shaped curve. Lancet 1981: 1 (8220 Pt 1): 580–3
   PubMed Web of Science ®Google Scholar
• Heinsimer JA, Irwin JM. Alcohol and the cardiovascular system. Cardiovasc Rev Reports 1986: 7(10): 848–60
   Google Scholar
• Burr ML, Fehily AM, Butland BK, et al. Alcohol and high-density-lipoprotein cholesterol: a randomized controlled trial. Br J Nutr 1986: 56(1): 81–6
   PubMed Web of Science ®Google Scholar
• Masarei JR, Puddey IB, Rouse IL, et al. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations: results from an intervention study in healthy subjects. Atherosderosis 1986: 60(1): 79–87
   PubMed Web of Science ®Google Scholar
• Diehl AK, Fuller JH, Mattock MB. et al. The relationship of high density lipoprotein subtractions to alcohol consumption, other lifestyle factors, and coronary heart disease. Atherosclerosis 1988: 69(2–3): 145–53
   PubMed Web of Science ®Google Scholar
• Criqui MH, Cowan LD, Tyroler HA, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up study. Am J Epidemiol 1987: 126(4): 629–37
   PubMed Web of Science ®Google Scholar
• Abbott RD, Wilson PW, Kannel WB, et al. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Arteriosclerosis 1988: 8(3): 207–11
   PubMedGoogle Scholar
• Brunner D, Weisbort J, Meshulam N, et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 1987: 59(15): 1271–6
   PubMed Web of Science ®Google Scholar
• Haskell WL, Camargo C Jr, Williams PT, et al. The effect of cessation and resumption of moderate alcohol Intake on serum high-density-lipoprotein subfractions: a controlled study. N Engl J Med 1984: 310(13): 805–10
   PubMed Web of Science ®Google Scholar
• Regan TJ. Alcoholic cardiomyopathy. Prog Cardiovasc Dis 1984: 27(3): 141–52
   PubMed Web of Science ®Google Scholar
• Ettinger PO, Wu CF, De La Cruz C Jr, et al. Arrhythmias and the “Holiday Heart”: alcohol-associated cardiac rhythm disorders. Am Heart J 1978: 95(5): 555–62
   PubMed Web of Science ®Google Scholar
• Koskinen P. Kupari M, Leinonen H. et al. Alcohol and new onset atrial fibrillation: a case-control study of a current series. Br Heart J 1987: 57(5): 468–73
   PubMedGoogle Scholar
• Klatsky AL, Friedman GD, Armstrong MA. The relationships between alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study. Circulation 1986: 73(4): 628–36
   PubMed Web of Science ®Google Scholar
• MacMahon S. Alcohol consumption and hypertension. Hypertension 1987: 9(2): 111–21
   PubMed Web of Science ®Google Scholar
• Donahue RP, Abbott RD, Reed DM, et al. Alcohol and hemorrhagic stroke: the Honolulu Heart Program. JAMA 1986: 255(17): 2311–4
   PubMed Web of Science ®Google Scholar
• Gordon T, Kannel WB. Drinking habits and cardiovascular disease: the Framingham Study. Am Heart J 1983: 105(4): 667–73
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988: 319(5): 267–73
   PubMed Web of Science ®Google Scholar